Adelaide Research & Scholarship: Search

Search

Results 11-20 of 77 (Search time: 0.002 seconds).

previous
1
2
3
4
5
...
8
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2018	CYP3A5*3 and ABCB1 61A>G significantly influence dose-adjusted trough blood tacrolimus concentrations in the first three months post-kidney transplantation	Hu, R.; Barratt, D.; Coller, J.; Sallustio, B.; Somogyi, A.
	2016	Allergy tests do not predict food triggers in adult patients with eosinophilic oesophagitis. A comprehensive prospective study using five modalities	Philpott, H.; Nandurkar, S.; Royce, S.; Thien, F.; Gibson, P.
	2004	Comparison of DNA damage and repair following radiation challenge in buccal cells and lymphocytes using single-cell gel electrophoresis	Dhillon, V.; Thomas, P.; Fenech, M.
	2021	Large variability in plasma efavirenz concentration in Papua New Guinea HIV/AIDS patients associated with high frequency of CYP2B6 516T allele	Bordin Andriguetti, N.; Van Schalkwyk, H.K.; Barratt, D.T.; Tucci, J.; Pumuye, P.; Somogyi, A.A.
	2013	TLR 2 and 4 responsiveness from isolated peripheral blood mononuclear cells from rats and humans as potential chronic pain biomarkers	Kwok, Y.; Tuke, S.; Nicotra, L.; Grace, P.; Rolan, P.; Hutchinson, M.; Price, T.J.
	1996	Effect of omeprazole and cimetidine on the urinary metabolic ratio of proguanil in volunteers.	Somogyi, A.; Reinhard, H.; Bochner, F.
	1999	Evaluation of the dose-response relationship for intra-nasal oxymetazoline hydrochloride in normal adults	Taverner, D.; Bickford, L.; Shakib, S.; Tonkin, A.
	2004	Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7	Toutsikos, P.; Miners, J.; Stapleton, A.; Thomas, A.; Sallustio, B.; Knights, K.
	2005	Short-term outcomes of five heroin detoxification methods in the Australian NEPOD project	Digiusto, E.; Lintzeris, N.; Breen, C.; Kimber, J.; Mattick, R.; Bell, J.; Ali, R.; Saunders, J.
	2007	The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after single increasing oral doses in healthy males	Sargentini-Maier, M.; Rolan, P.; Connell, J.; Tytgat, D.; Jacobs, T.; Pigeolet, E.; Riethuisen, J.; Stockis, A.